Trial Profile
Safety, Tolerability and Activity of oral GS 4104 (Ro 64-0796) in Treatment of Subjects experimentally Inoculated with Human Influenza Virus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Roche
- 05 Nov 2010 New trial record.